Verteporfin: all 37 studies that test it
Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- SCARFREE-001: Verteporfin for Scar PreventionNot yet recruitingNCT07488988Phase 2
- Effect of YAP1-inhibition in Surgical Wounds.Not yet recruitingNCT06944249Phase 1/2
- Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 SystemRecruitingNCT06807359Phase 1/2
- Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway ObstructionRecruitingNCT06306638Phase 1/2
- Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated GlioblastomaRecruitingNCT04590664Phase 1/2
- Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 SystemRecruitingNCT03067051Phase 1/2
- Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 StudyCompletedNCT03033225Phase 2Results posted
- Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous ChorioretinopathyCompletedNCT01325181Phase 1/2Results posted
- Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal VasculopathyCompletedNCT00674323Phase 4Results posted
- Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)CompletedNCT00492284Phase 2Results posted
- Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular DegenerationCompletedNCT00473642Phase 4Results posted
- Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal NeovascularizationCompletedNCT00436553Phase 3Results posted
- Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)TerminatedNCT00433017Phase 2/3Results posted
- Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic CancerActive, not recruitingNCT06381154Phase 2
- Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple TherapyWithdrawnNCT04075136Phase 4
- Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN RegimenCompletedNCT03459144Not applicable
- An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast CancerStatus unknownNCT02939274Phase 2
- Treatment of Primary Breast Cancer Using PDTCompletedNCT02872064Not applicable
- Photo-induction as a Means to Improve Cisplatin Delivery to Pleural MalignanciesTerminatedNCT02702700Phase 1
- Photodynamic Therapy for the Treatment of Vertebral MetastasesCompletedNCT02464761Phase 1
- Cohort Study of the Clinical Course of Macular Diseases in KagawaStatus unknownNCT02321267Phase 4
- ICG-Guided Photodynamic Therapy for Treatment of Retinal Capillary Abnormalities: A Pilot StudyStatus unknownNCT01974622Not applicable
- A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in EyesTerminatedNCT01746875Not applicable
- Lucentis KAV StudyCompletedNCT01570608Phase 3
- Central Serous Chorioretinopathy Treated by Modified Photodynamic TherapyCompletedNCT01019668Not applicable
- Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMDCompletedNCT00574093Phase 2
- Photodynamic and Pharmacologic Treatment of CNVCompletedNCT00570193Phase 1/2
- Second Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by ItselfWithdrawnNCT00457678Phase 2
- Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMDCompletedNCT00426998Phase 2
- Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular DegenerationCompletedNCT00390208Phase 2
- Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMDStatus unknownNCT00370539Phase 3
- Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC)CompletedNCT00211445Phase 2
- Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular DegenerationCompletedNCT00140803Phase 2
- Photodynamic Therapy in Occult-Only Lesions (POOL)CompletedNCT00135837Phase 4
- Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)TerminatedNCT00134667Phase 4
- Visudyne® in Occult (VIO)CompletedNCT00121407Phase 3
- Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain TumorsStatus unknownNCT00002647Phase 1